• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Aptamers and antibodies: rivals or allies in cancer targeted therapy?”.
    No. Publication Date Citing Article
    1 2022 Simona Camorani, Silvia Tortorella, Lisa Agnello, Chiara Spanu, Annachiara d’Argenio, Roberto Nilo, Antonella Zannetti, Erica Locatelli, Monica Fedele, Mauro Comes Franchini, Laura Cerchia. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells, Pharmaceutics. 2022; 14: 2225.  https://doi.org/10.3390/pharmaceutics14102225
    2 2023 Martin Panigaj, Elizabeth Skelly, Damian Beasock, Ian Marriott, M. Brittany Johnson, Jacqueline Salotti, Kirill A. Afonin. Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles, Frontiers in Immunology. 2023; 14: 1053550.  https://doi.org/10.3389/fimmu.2023.1053550
    3 2021 Sarah Shigdar, Lisa Agnello, Monica Fedele, Simona Camorani, Laura Cerchia. Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof, Pharmaceutics. 2021; 14: 28.  https://doi.org/10.3390/pharmaceutics14010028
    4 2023 Marco Arese, Mohammad Mahmoudian, Federico Bussolino. RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions, Expert Opinion on Drug Delivery. 2023; 20: 1609.  https://doi.org/10.1080/17425247.2023.2292691